BIOBio-Rad Laboratories, Inc.
286.74USDMkt Cap: 7.67B USDP/E: 47.63Last update: 2026-05-21

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates throug…

loading…
Indicators:|

Key Statistics

Company
Market Cap7.67B USD
Enterprise Value7.49B USD
Revenue (TTM)2.59B USD
Gross Profit1.34B USD
Net Income (TTM)759.90M USD
Revenue/Share95.80 USD
Last Price286.74 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS0905722072
Valuation
P/E (Trailing)47.63
P/E (Forward)29.25
PEG4.01
EV/EBITDA16.83
EV/Revenue2.89
P/S2.96
P/B1.12
EPS (TTM)6.02
EPS (Forward)9.80
52W Range
281.8656% of range290.55
52W High290.55 USD
52W Low281.86 USD
Profitability
Gross Margin51.87%
Oper. Margin5.76%
EBITDA Margin17.17%
Profit Margin29.42%
ROE10.20%
ROA7.18%
Growth
Revenue Growth1.10%
Earnings Growth
Cash Flow & Leverage
Operating CF532.20M USD
CapEx (TTM)157.60M USD
FCF Margin8.87%
FCF Yield2.99%
Net Debt-186.50M USD
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity0.19
Current Ratio3.21
Quick Ratio2.19
Book Value/Sh255.37 USD
Cash/Share58.47 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split2:1
Split DateMar 8, 2002
Analyst Consensus
Rating2.8 (Hold)
Target (Mean)293.00 USD
Target Range275.00 USD320.00 USD
# Analysts5
Ownership
Shares Out.21.70M
Float20.90M
Insiders16.38%
Institutions94.47%
Short Interest
Short Ratio0.0d
Short % Float0.00%
Short % Out.0.00%
Shares Short34
Short (prev mo.)26
Technical
SMA 50273.55 (+4.8%)
SMA 200292.57 (-2.0%)
Beta1.06
S&P 52W Chg28.31%
Avg Vol (30d)190.51K
Avg Vol (10d)486.70K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)